Citation Impact
Citing Papers
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
AMPK: guardian of metabolism and mitochondrial homeostasis
2017 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
The MAGE protein family and cancer
2015
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Degradation of AMPK by a Cancer-Specific Ubiquitin Ligase
2015
To repress or not to repress: This is the guardian's question
2011
p53-Dependent and Cell Specific Epigenetic Regulation of the Polo-like kinases under Oxidative Stress
2014
Checkpoint control and cancer
2011
Pim kinases in cancer: Diagnostic, prognostic and treatment opportunities
2012
Uptake routes of tumor-antigen MAGE-A3 by dendritic cells determine priming of naïve T-cell subtypes
2012
Polo-like kinase 1 inhibitors, mitotic stress and the tumor suppressor p53
2013
A Comprehensive Guide to the MAGE Family of Ubiquitin Ligases
2017
Oxidative Stress in Cancer
2020 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Cyclin B2 and p53 control proper timing of centrosome separation
2014
ROS and the DNA damage response in cancer
2018 Standout
Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application
2019
Genome Regulation by Long Noncoding RNAs
2012 Standout
Molecular Docking and Structure-Based Drug Design Strategies
2015 Standout
Cancer Genome Landscapes
2013 StandoutScience
Oncogenic cancer/testis antigens: prime candidates for immunotherapy
2015
Works of Lynnette Marcar being referenced
Mage-A Cancer/Testis Antigens Inhibit p53 Function by Blocking Its Interaction with Chromatin
2010
Elevated Levels of Oncogenic Protein Kinase Pim-1 Induce the p53 Pathway in Cultured Cells and Correlate with Increased Mdm2 in Mantle Cell Lymphoma
2008
p53-dependent repression of polo-like kinase-1 (PLK1)
2010
Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity
2019
MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4
2015